Empery Asset Management, LP 13D and 13G filings for Outlook Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-21 09:00 am Sale | 2025-09-30 | 13G | Outlook Therapeutics, Inc. OTLK | Empery Asset Management, LP | 2,332,948 4.990% | -862,693 (-27.00%) | Filing |
| 2025-07-31 4:35 pm Purchase | 2025-06-30 | 13G | Outlook Therapeutics, Inc. OTLK | Empery Asset Management, LP | 3,195,641 7.570% | 3,195,641 (New Position) | Filing |